Viewing Study NCT04082260


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-01-07 @ 11:26 AM
Study NCT ID: NCT04082260
Status: UNKNOWN
Last Update Posted: 2019-09-20
First Post: 2019-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Signatures of Immune Reprogramming in Anti-CD52 Therapy of MS: Markers for Risk Stratification and Treatment Response
Sponsor: University Hospital Muenster
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module